|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Cash flows from operating activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Investment income earned on investments held in Trust Account | ||
| Offering costs associated with warrants recorded as liabilities | ||
| Change in fair value of warrant liabilities | ||
| Excess of fair value over cost on sale of Private Placement Warrants | ||
| Changes in operating assets and liabilities | ||
| Prepaid expenses | ||
| Accrued expenses | ||
| Accrued expenses - related party | ||
| Payment of formation costs through issuance of Class B ordinary shares | ||
| Net cash used in operating activities | ||
| Cash flows from investing activities: | ||
| Cash deposited in Trust Account | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities: | ||
| Proceeds received from working capital loan | ||
| Proceeds received from initial public offering, gross | ||
| Proceeds received from sale of Private Placement Warrants | ||
| Payment of underwriter commissions | ||
| Payment of offering costs | ||
| Net cash provided by financing activities | ||
| Net change in cash | ||
| Cash – beginning of period | ||
| Cash – end of period | ||
| Supplemental disclosure of non-cash activities | ||
| Deferred offering costs included in accrued offering costs | ||
| Formation and offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares | ||
| Deferred offering costs paid by the Sponsor through promissory note | ||
| Accrued offering costs | ||
| Deferred underwriter’s commissions in connection with the initial public offering |
Loading...
